Why Smart Teams Disagree: The Hidden Biology Behind Team Decisions

The standard script has been: dopamine drives reward, serotonin manages mood. But a recent first-in-human study shows something far more interesting – both systems actively shape social decision-making, in real time, and they do it differently.

What researchers found (in actual human brains)

During awake neurosurgery, four Parkinson’s patients played the ultimatum game – deciding whether to accept or reject offers that varied in fairness, coming from either a person or a computer. While they made these choices, researchers measured dopamine and serotonin simultaneously in the substantia nigra with sub-second precision.

The result: two complementary value signals running in parallel.

  • Dopamine tracked opportunity. Dopamine levels shifted based on whether an offer was better or worse than the previous one. In other words: dopamine wasn’t just saying “reward.” It was saying “Is this better than last time?”
  • Serotonin tracked the value of the offer right now. It ignored the previous offer and serotonin levels reflected only the current one. Serotonin’s message was simple: “Given what this is, is it worth accepting?”

Our decisions aren’t driven by a single internal voice. They’re shaped by a blend of opportunity-sensing (dopamine) and present-value testing (serotonin). Every person uses both – although we each tend to lead with one.

What does this mean for leaders and teams?

This biology explains a familiar kind of friction:

  • Opportunity-led people look at a deal, plan, or strategy and feel the pull of what could be next. They expand the option set, spot upside others miss, and keep teams evolving rather than settling. They may label caution as “closed off” or “missing the possibilities.”
  • Present-value-led people look at the same moment and protect the “bird in hand.” They keep teams from endlessly “improving” the status quo when it doesn’t actually add value — helping bank real wins, avoid pointless churn, and use time and resources wisely. They may label opportunity-focus as “the next shiny thing” or “stretching past what we need.”

If you don’t name these two lenses, you get predictable dysfunction. The difference starts to create misalignment and conflict.

What great leaders do instead

They shape the decision process so both perspectives show up in every meaningful choice. Steer the discussion so the team names the opportunity on the table, then tests the tradeoffs and present value, before committing. Ensure that the final call is stronger than any single viewpoint.

Build these two questions into every important decision:

  • Opportunity check (dopamine / Yellow): “Is this trending better than before? What upside are we seeing?”
  • Adequacy check (serotonin / Blue): “If this were the first offer, would we take it as-is? What’s missing?”

Why it matters

Teams that only reward opportunity can keep chasing “better” without real payoff. Teams that only reward adequacy can stall while waiting for perfect clarity. The best teams integrate both – pursuing meaningful upside while staying grounded in what’s real and worthwhile.

NeuroColor translation for team health

  • Those high in Yellow are your opportunity radar.
  • Those high in Blue are your value integrity system.

Neither is optional. Together, they make decisions that are both possibility-driven and thoroughly vetted.

Next step:

If this resonates, here’s a useful next step: get clear on which lens you naturally lead with.

NeuroColor translates these brain-based patterns into your real-world decision style – how you spot opportunity, how you test present value, and where you might over- or under-weight one side under pressure.

When you know your NeuroColor results (and your team’s), the friction described above gets a lot easier to navigate. You can name what’s happening while it’s happening and design decisions that use everyone’s strengths.

FAQ

Q1: If everyone uses both systems, why do teams still split?
A: Because under pressure, people default to their lead lens. One person leads with possibility; another leads with adequacy. Both are making an essential value judgment – but they’re anchoring that judgment to different time frames.

  • One person is valuing future upside: “How much better could this get compared to where we were?”
  • The other is valuing present adequacy: “How good is this offer as it stands right now?”

The disagreement isn’t about who’s “right.” It’s about whether the decision should prioritize potential value later or solid value now.

Q2: What’s a fast facilitation move if the room polarizes?
A:
Name the lenses out loud and run them in sequence:

  1. “What’s the real opportunity here?” (Yellow/dopamine lead)
  2. “What’s the present value and tradeoff?” (Blue/serotonin lead)

When people see their lens is expected, defensiveness drops and the decision sharpens.

Q3: What’s the risk of over-indexing on Yellow/dopamine?
A:
You can end up optimizing for “better than before” even when the gain is marginal — chasing upgrades that don’t materially improve outcomes. The team stays excited but doesn’t lock in meaningful gains.

Q4: What’s the risk of over-indexing on Blue/serotonin?
A:
You can protect today’s value so well that you miss tomorrow’s meaningful upside. The team stays stable but may under-explore.

Q5: How can leaders design meetings to use both lenses, not just tolerate them?
A: Build it into the agenda:

  • Start with opportunity framing (options, upside, comparisons).
  • Then do a present-value pass (what’s solid, what’s the cost, what are we giving up).

The leader’s job is to keep the room from skipping either step.

Q6: How can this be used to coach people through conflict on a team?
A:
It reframes tension from “personality clash” to “value timing.” Both people are protecting value – one in the future, one in the present. That reframing can lower defensiveness and make it easier for people to reconnect and get on the same page.